banner
ALK inhibitor ALK-IN-1, Purity ≥98%
Inquiry

Cat. No.: X24-06-ZQ295

ALK inhibitor ALK-IN-1, Purity ≥98%

Synonym: 1197958-12-5; ALK inhibitor; AP-26113

  • MDL: MFCD23704187
  • CAS Number: 1197958-12-5
  • Compound CID: 57390074
img
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
ALK-IN-1, soluble in DMSO and ethanol and insoluble in water, is a protein tyrosine kinase inhibitor that has shown potent biochemical activity against ALK. It targets FER, ROS/ROS1, Abl1, ALK, ARK5, Aurora A, BLK, BRK, BRSK1, BRSK2, BTK.
Molecular Weight
529.01
Molecular Formula
C26H34ClN6O2P
Targets
FER: 1.3 nM; ROS/ROS1: 1.9 nM; Abl1: 500 nM; ALK: 0.62 nM; ARK5: 47 nM; AuroraA: 146 nM; BLK: 136 nM; BRK: 4.1 nM; BRSK1: 338 nM; BRSK2: 125 nM; BTK: 673 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 40 mg/mL (75.61 mM); Water: Insoluble; Ethanol: 93 mg/mL (175.8 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
ALK-IN-1 is used to investigate ALK inhibition, which plays a critical role in developing treatments for ALK-positive cancers.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0